Published: 4/10/2026 9:03:08 AM
This is a news from the Finwire news agency Disclaimer
The biotechnology company Bio-Works' nomination committee proposes the election of Eva Lindskog and Andrea Ballagi to the board ahead of the annual general meeting this spring. At the same time, the re-election of the incumbent members and of Peter Ehrenheim as chair is proposed.Lindskog is currently Chief Commercial Officer at NanoTemper Technologies and has a long background in the life science industry. Ballagi likewise has a long background in the industry and today holds global responsibility for market development in oncology at Olink Proteomics, a company that now forms part of the giant Thermo Fisher Scientific.
Read more about Bio-Works Technologies AB